Head and neck cancer

New England Journal of Medicine

Volumn 345, Issue 26, 2001, Pages 1890-1900

  Forastiere, Arlene ^a   Koch, Wayne ^a   Trotti, Andrew ^a   Sidransky, David ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT CHEMOTHERAPY; CANCER STAGING; DISEASE COURSE; HEAD AND NECK TUMOR; HUMAN; METASTASIS; MULTIMODALITY CANCER THERAPY; MULTIPLE CANCER; REVIEW; TUMOR RECURRENCE;

ANTINEOPLASTIC AGENTS; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; HEAD AND NECK NEOPLASMS; HUMAN; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASMS, MULTIPLE PRIMARY; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0035960866     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMra001375     Document Type: Article

References (10)

1. Vokes EE, Weichselbaum RR, Lippman SM, Hong WK. Head and neck cancer. N Engl J Med 1993;328:184-94.
2. Canto MT, Devesa SS. Oral cavity and pharynx cancer incidence rates in the United States 1975-1998. Oral Oncol (in press).
3. Hibi K, Trink B, Patturajan M, et al. AIS is an oncogene amplified in squamous cell carcinoma. Proc Natl Acad Sci U S A 2000;97:5462-7.
4. Mills AA, Zheng B, Wang X-J, Vogel H, Roop DR, Bradley A. p63 Is a p53 homologue required for limb and epidermal morphogenesis. Nature 2001;398:708-13.
5. Fearon ER, Vogelstein B. A genetic model of colorectal tumorigenesis. Cell 1990;61:759-67.
6. Califano J, van der Riet P, Westra W, et al. Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res 1996;56:2488-92.
7. van der Riet P, Nawroz H, Hruban RH, et al. Frequent loss of chromosome 9p21-22 early in head and neck cancer progression. Cancer Res 1994;54:1156-8.
8. Cairns P, Polascik TJ, Eby Y, et al. Frequency of homozygous deletion at p16/CDKN2 in primary human tumours. Nat Genet 1995;11:210-2.
9. Kamb A, Gruis NA, Weaver-Feldhaus J, et al. A cell cycle regulator potentially involved in genesis of many tumor types. Science 1994;264:436-40.
10. Reed A, Califano J, Cairns P, et al. High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma. Cancer Res 1996;56:3630-3.